![](/img/cover-not-exists.png)
300 Guselkumab attenuates disease- and mechanism-related biomarkers in patients with moderate-to-severe plaque psoriasis
Branigan, P.J., Liu, X., Chen, Y., Ma, K., Scott, B., McGovern, P., Munoz-Elias, E., Campbell, K.Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.02.316
Date:
May, 2017
File:
PDF, 236 KB
english, 2017